feed,title,long_url,short_url
BioRxiv,High neutralizing potency of swine glyco-humanized polyclonal antibodies against SARS-CoV-2,https://biorxiv.org/cgi/content/short/2020.07.25.217158v1?rss=1,https://j.mp/3eY7azf
BioRxiv,SARS-CoV-2 differs from SARS-CoV in the requirements for receptor expression and proteolytic activation to trigger cell-cell fusion and is not inhibited by Bromhexine,https://biorxiv.org/cgi/content/short/2020.07.25.221135v1?rss=1,https://j.mp/331oyB3
BioRxiv,Î²-Coronaviruses use lysosomal organelles for cellular egress,https://biorxiv.org/cgi/content/short/2020.07.25.192310v1?rss=1,https://j.mp/301Jplu
BioRxiv,Rapid generation of circulating and mucosal decoy ACE2 using mRNA nanotherapeutics for the potential treatment of SARS-CoV-2,https://biorxiv.org/cgi/content/short/2020.07.24.205583v1?rss=1,https://j.mp/32TpwyW
